Applications

Meridian Biologics Pty Ltd · Northside Clinical Research Unit

Progress report due. NCR-ASTH-003 (VH-2025-0017) expires 14 Jan 2027. Submit the annual progress report by 15 Dec 2026 to keep approval continuous. Start progress report

Next committee meeting: Wednesday 18 November 2026. Agenda closes Thursday 12 November, 5 pm AEDT. Applications submitted after that are reviewed on 25 November.

Bulk actions

Search applications

Application	Type	Investigator	Status	Next action	Meeting	Expires
MB-IL22-001 · Phase 1 FIH, anti-IL-22 monoclonal antibody VH-2026-0041 Respond to comments \| View \| History \| PDF	New study	Dr Priya Raman	Comments received · Cycle 1	Respond to 6 comments; due 9 May 2027	11 Nov 2026	—
MB-TSLP-002 · Phase 1 FIH, anti-TSLP VH-2026-0046 Fix 3 return notes \| Edit \| History	New study	Dr Priya Raman	Returned	Fix return notes and resubmit to make the 18 Nov agenda	—	—
NCR-DERM-104 · Phase 2, topical JAK inhibitor VH-2026-0049 Continue editing \| Preview PDF \| Delete draft	New study	Dr Tom Whitfield	In preparation	Page 6 of 7 · PI attestation pending	—	—
NCR-ASTH-003 · Amendment 4, Protocol v6.0 VH-2025-0017-A-4 History \| View	Amendment	Dr Priya Raman	Under review	Assigned to Committee A; decision within 2 business days of meeting	11 Nov 2026	14 Jan 2027
NCR-ASTH-003 · Phase 1a/1b, inhaled biologic in mild asthma VH-2025-0017 History \| Start amendment \| Safety report \| Serious breach \| Progress report \| Approval letter	New study	Dr Priya Raman	Approved	Progress report due 15 Dec 2026	3 Dec 2025	14 Jan 2027
NCR-ASTH-003 · Serious breach report 1 VH-2025-0017-PVR-1 History \| Acknowledgment letter	Serious breach	Dr Priya Raman	Acknowledged	CAPA follow-up due 30 Jun 2027	24 Jun 2026	—
NCR-ONC-002 · Final report VH-2025-0009-FR-1 History \| Closure letter	Final report	Dr Tom Whitfield	Closed	Read-only	16 Mar 2026	—

7 of 9 items shown Expired approvals and closed studies stay listed for reference and audit; nothing is ever deleted after submission.